New CNAS Regulations May Delay Elderly Patients' Access to Oncological Treatments

Recent changes made by the National Health Insurance House to national health programmes are causing concern among private healthcare providers, who are warning of the negative impact on oncological treatments.

The Employers' Association of Private Medical Service Providers has signalled that the new regulations risk significantly delaying patients' access to vital treatments, reducing their chances of survival. This situation particularly affects elderly people, who represent a significant proportion of cancer patients.

Data show that the private sector plays a crucial role in the Romanian healthcare system, accounting for nearly 79% of specialist clinical service providers. In oncology, the dependence on the private sector is even greater: 88% of drug treatment services and 82% of radiotherapy treatments are provided by private clinics.

The medical organisation highlights that these changes appear to ignore the reality that the private sector employs approximately 43% of Romania's medical staff. This concentration of resources in the private sector means that any disruption to collaboration with the CNAS has an immediate impact on patients.

The greatest concern relates to oncological treatments, where time is of the essence. The organisation criticises the fact that for the authorities "it seems not to matter whether a cancer patient begins treatment today or in three months' time" — a delay that can be decisive for a patient's prognosis.

The situation raises important questions about continuity of care for patients already enrolled in programmes and about the fate of contracts currently underway. Elderly people, who typically require complex and long-term treatments, could be the most affected by these administrative uncertainties.